Welcome to Due Diligence, the FT’s daily deals briefing
Related Posts
- Chinese Biopharma Firm CANbridge Life Sciences Raises $25M In Series B Round
- Matrix Partners Leads $15M Series B For App Maker Meet You
- Chip Design Platform MooreElite Secures Series B Round
- The transatlantic trade rift is far from fixed
- GIC Invests $85M In Chinese Biomedicine Firm Bloomage
- Myanmar tycoon champions $1.5bn China-backed project
- China’s distressed asset funds struggle to profit from collapsing property sector
- FirstFT: China’s Xi resists pressure to ditch Putin
- Fabian Schneider
- China's Millennials Drive Country's Outbound Travel Spending To $229B In 2015